ADPT
Adaptive Biotechnologies Corporation
Stock
$28.35+0.98 (+3.58%)Close Oct 2, 2026
- EBITDA, 2025
- −$41M
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | −$41M | — |
| 2024 | −$145M | — |
| 2023 | −$207M | — |
| 2022 | −$181M | — |
| 2021 | −$197M | — |
| 2020 | −$146M | — |
| 2019 | −$72M | — |
| 2018 | −$45M | — |
| 2017 | −$40M | — |